Results 1 to 10 of about 273,629 (190)
Complex Adaptive Immunity to enteric fevers in humans: Lessons learned and the path forward
Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, and S. Paratyphi A and B, causative agents of paratyphoid fever, are major public health threats throughout the world.
Marcelo B. Sztein +2 more
doaj +1 more source
Enteric fever is a systemic infection caused by Salmonella Typhi or Paratyphi A. In many endemic areas, these serovars co-circulate and can cause multiple infection-episodes in childhood.
Malick M Gibani +24 more
doaj +1 more source
A Highly Effective Component Vaccine against Nontyphoidal
Nontyphoidal Salmonella enterica (NTS) infections are a major burden to global public health, as they lead to diseases ranging from gastroenteritis to systemic infections and there is currently no vaccine available.
Rosana B. R. Ferreira +19 more
doaj +1 more source
Design of a Glycoconjugate Vaccine Against Salmonella Paratyphi A
Background/Objectives: Typhoid and paratyphoid fever together are responsible for millions of cases and thousands of deaths per year, most of which occur in children in South and Southeast Asia.
Renzo Alfini +8 more
doaj +1 more source
Typhoid and Paratyphoid fever cause a global health burden, especially for the children of Southern Asia. The impact of the disease is further exacerbated by the dramatic increase of antimicrobial resistance.
Martina Carducci +15 more
doaj +1 more source
Background: Typhoid and paratyphoid fevers represent a global health burden, especially in Southern Asia, exacerbated by the increase in antimicrobial resistance.
Marika Pinto +11 more
doaj +1 more source
The aim of this article was to show the labor valour during the Great Patriotic War of the employees of the first research institute in Irkutsk, which began its history in 1912, as well as their success of the present time.
G. A. Danchinova +4 more
doaj +1 more source
OBJECTIVE: To carry out a comparative study of the safety and immunogenicity of Vi polysaccharide vaccine against whole-cell killed (WCK) typhoid vaccine.
Panchanathan Vijayaretnam +10 more
doaj
Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China
OBJECTIVE: To test the efficacy of locally produced Vi vaccine over a time period of longer than one year. METHODS: A double-blinded, randomized field trial was performed in Guangxi Zhuang Autonomous Region in south-western China, using 30 mg doses of ...
Yang H.H. +19 more
doaj
In July last year, at the time the first issue of the Journal of Infection in Developing Countries was going to press, a group of infectious disease experts met in Siena, Italy, to consider the direction of another important new initiative in the fight ...
Allan Saul, Rino Rappuoli.
doaj

